+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Middle East in Vitro Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents), by Test Location, by End-use (Hospitals, Laboratory), by Application, by Technology, by Region, and Segment Forecasts, 2025-2033

  • PDF Icon

    Report

  • 320 Pages
  • August 2025
  • Region: Middle East
  • Grand View Research
  • ID: 6168273
REQUEST CUSTOMIZATION
Description Jump to:
The Middle East in vitro diagnostics market size was estimated at USD 2.09 billion in 2024 and is projected to reach USD 3.79 billion by 2033, growing at a CAGR of 7.25% from 2025 to 2033. The market is driven by a combination of rising disease prevalence, expanding healthcare infrastructure, and increased investments in early disease detection.

Chronic diseases such as diabetes, cardiovascular disorders, and cancer are on the rise in the region, prompting governments and healthcare providers to prioritize advanced diagnostic testing to improve patient outcomes. According to the World Health Organization (WHO), cancer incidence in the Middle East is expected to double by 2033, with 9 out of 22 countries in the region lacking optimal operational facilities to manage cancer effectively. This unmet need for early diagnosis and treatment, coupled with economic development in emerging markets like Qatar, is creating substantial opportunities for the IVD market.

The Saudi Arabia in vitro diagnostics market is experiencing robust growth, fueled by the increasing prevalence of both communicable and noncommunicable diseases (NCDs), as well as rising awareness and government initiatives to improve healthcare outcomes. The country faces a growing burden of NCDs, such as cardiovascular diseases (CVDs) and diabetes, largely attributed to sedentary lifestyles. In addition, cancers such as lung, colorectal, stomach, breast, and prostate are major causes of cancer-related deaths. According to ScienceDirect, the prevalence of CVDs in Saudi Arabia is projected to reach 479,500 cases by 2035, while over 31,000 new cancer cases were anticipated to be diagnosed in 2023.

Middle East In Vitro Diagnostics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. The analyst has segmented the Middle East in vitro diagnostics market report based on products, technology, application, test location, end use, and region.

Product Outlook (Revenue, USD Million, 2021-2033)

  • Instruments
  • Reagents
  • Others

Technology Outlook (Revenue, USD Million, 2021-2033)

  • Immunoassay
  • Instruments
  • Reagents
  • Others
  • Hematology
  • Instruments
  • Reagents
  • Others
  • Clinical Chemistry
  • Instruments
  • Reagents
  • Others
  • Molecular Diagnostics
  • Instruments
  • Reagents
  • Others
  • Coagulation
  • Instruments
  • Reagents
  • Others
  • Microbiology
  • Instruments
  • Reagents
  • Others
  • Others
  • Instruments
  • Reagents
  • Others

Application Outlook (Revenue, USD Million, 2021-2033)

  • Infectious Diseases
  • Diabetes
  • Oncology
  • Cardiology
  • Nephrology
  • Autoimmune Diseases
  • Drug Testing
  • Other applications

Test Location Outlook (Revenue, USD Million, 2021-2033)

  • Point of Care
  • Home-care
  • Others

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Hospitals
  • Laboratory
  • Home Care
  • Others

Regional Outlook (Revenue, USD Million, 2021-2033)

  • Middle East and Africa (MEA)
  • Saudi Arabia
  • UAE
  • Kuwait
  • Qatar
  • Oman

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the industry across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segmental and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product
1.2.2. Technology
1.2.3. Application
1.2.4. Test Location
1.2.5. End Use
1.3. Regional Scope
1.4. Estimates and Forecast Timeline
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.7. Details of primary research
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity flow analysis (Model 1)
1.9.1.1. Approach 1: Commodity flow approach
1.9.2. Volume price analysis (Model 2)
1.9.2.1. Approach 2: Volume price analysis
1.10. Research Scope and Assumptions
1.10.1. List of Secondary Sources
1.10.2. List of Primary Sources
1.10.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Middle East in Vitro Diagnostics Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Introduction of Technologically Advanced Products
3.2.1.2. Increasing Demand for PoC Testing
3.2.1.3. Growing Prevalence of Target Diseases
3.2.1.4. Increasing External Funding for R&D
3.2.2. Market Restraints Analysis
3.2.2.1. Presence of Ambiguous Regulatory Framework
3.2.2.2. High Capital Investment
3.2.2.3. High Prices of Molecular Diagnostic Tests
3.2.3. Market Opportunity Analysis
3.2.4. Supply Chain Analysis
3.2.5. Distribution Channel
3.2.5.1. Direct Sales
3.2.5.2. Distributors Network
3.2.5.3. E-commerce and Online Platforms
3.2.5.4. Major Distributors
3.3. Middle East in Vitro Diagnostics Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Legal landscape
3.4. Reimbursement Overview of IVDs and LDTs
3.5. Pricing Analysis
Chapter 4. Middle East in Vitro Diagnostics Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Middle East in Vitro Diagnostics Market: Product Movement Analysis, 2024 & 2033 (USD Million)
4.3. Instruments
4.3.1. Instruments Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.4. Reagents
4.4.1. Reagents Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5. Services
4.5.1. Services Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. Middle East in Vitro Diagnostics Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Middle East in Vitro Diagnostics Market: Technology Movement Analysis, 2024 & 2033 (USD Million)
5.3. Immunoassay
5.3.1. Immunoassay Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.3.2. Instruments
5.3.2.1. Instruments Market Revenue Estimates and Forecasts, 2021-2033 (USD Million) (Volume, Number of Units)
5.3.3. Reagents
5.3.3.1. Reagents Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.3.4. Services
5.3.4.1. Services Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.4. Hematology
5.4.1. Hematology Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.4.2. Instruments
5.4.2.1. Instruments Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.4.3. Reagents
5.4.3.1. Reagents Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.4.4. Services
5.4.4.1. Services Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.5. Clinical Chemistry
5.5.1. Clinical Chemistry Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.5.2. Instruments
5.5.2.1. Instruments Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.5.3. Reagents
5.5.3.1. Reagents Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.5.4. Services
5.5.4.1. Services Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.6. Molecular Diagnostics
5.6.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.6.2. Instruments
5.6.2.1. Instruments Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.6.3. Reagents
5.6.3.1. Reagents Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.6.4. Services
5.6.4.1. Services Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.7. Coagulation
5.7.1. Coagulation Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.7.2. Instruments
5.7.2.1. Instruments Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.7.3. Reagents
5.7.3.1. Reagents Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.7.4. Services
5.7.4.1. Services Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.8. Microbiology
5.8.1. Microbiology Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.8.2. Instruments
5.8.2.1. Instruments Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.8.3. Reagents
5.8.3.1. Reagents Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.8.4. Services
5.8.4.1. Services Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.9. Others
5.9.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.9.2. Instruments
5.9.2.1. Instruments Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.9.3. Reagents
5.9.3.1. Reagents Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.9.4. Services
5.9.4.1. Services Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. Middle East in Vitro Diagnostics Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Middle East in Vitro Diagnostics Market: Application Movement Analysis, 2024 & 2033 (USD Million)
6.3. Infectious Disease
6.3.1. Infectious Disease Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.4. Diabetes
6.4.1. Diabetes Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.5. Oncology/Cancer
6.5.1. Oncology/Cancer Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.6. Cardiology
6.6.1. Cardiology Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.7. Nephrology
6.7.1. Nephrology Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.8. Autoimmune Diseases
6.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.9. Drug Testing
6.9.1. Drug Testing Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.10. Others
6.10.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Middle East in Vitro Diagnostics Market: Test Location Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Middle East in Vitro Diagnostics Market: Test Location Movement Analysis, 2024 & 2033 (USD Million)
7.3. Point of Care
7.3.1. Point of Care Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
7.4. Home-care
7.4.1. Home-care Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
7.5. Others
7.5.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 8. Middle East in Vitro Diagnostics Market: End Use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Middle East in Vitro Diagnostics Market: End Use Movement Analysis, 2024 & 2033 (USD Million)
8.3. Hospitals
8.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
8.4. Laboratory
8.4.1. Laboratory Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
8.5. Home Care
8.5.1. Home Care Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
8.6. Others
8.6.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 9. Middle East in Vitro Diagnostics Market: Regional Estimates & Trend Analysis
9.1. Middle East in Vitro Diagnostics Market Share, by Region, 2024 & 2033 (USD Million)
9.2. Middle East and Africa
9.2.1. Middle East and Africa Middle East in Vitro Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
9.2.2. Saudi Arabia
9.2.2.1. Key Country Dynamics
9.2.2.2. Regulatory Landscape/Reimbursement Scenario
9.2.2.3. Competitive Insights
9.2.2.4. Saudi Arabia Middle East in Vitro Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
9.2.3. UAE
9.2.3.1. Key Country Dynamics
9.2.3.2. Regulatory Landscape/Reimbursement Scenario
9.2.3.3. Competitive Insights
9.2.3.4. UAE Middle East in Vitro Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
9.2.4. Qatar
9.2.4.1. Key Country Dynamics
9.2.4.2. Regulatory Landscape/Reimbursement Scenario
9.2.4.3. Competitive Insights
9.2.4.4. Qatar Middle East in Vitro Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
9.2.5. Kuwait
9.2.5.1. Key Country Dynamics
9.2.5.2. Regulatory Landscape/Reimbursement Scenario
9.2.5.3. Competitive Insights
9.2.5.4. Kuwait Middle East in Vitro Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
9.2.6. Oman
9.2.6.1. Key Country Dynamics
9.2.6.2. Regulatory Landscape/Reimbursement Scenario
9.2.6.3. Competitive Insights
9.2.6.4. Kuwait Middle East in Vitro Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis by Key Market Participants
10.2. Company Categorization
10.3. Company Market Share Analysis, 2024
10.4. Company Heat Map Analysis
10.5. Strategy Mapping
10.5.1. Expansion
10.5.2. Mergers & Acquisition
10.5.3. Partnerships & Collaborations
10.5.4. New Product Launches
10.5.5. Research and Development
10.6. Company Profiles
10.6.1. Abbott
10.6.1.1. Participant’s Overview
10.6.1.2. Financial Performance
10.6.1.3. Product Benchmarking
10.6.1.4. Recent Developments
10.6.2. Bio-Rad Laboratories, Inc
10.6.2.1. Participant’s Overview
10.6.2.2. Financial Performance
10.6.2.3. Product Benchmarking
10.6.2.4. Recent Developments
10.6.3. Siemens Healthineers AG
10.6.3.1. Participant’s Overview
10.6.3.2. Financial Performance
10.6.3.3. Product Benchmarking
10.6.3.4. Recent Developments
10.6.4. BIOMÉRIEUX
10.6.4.1. Participant’s Overview
10.6.4.2. Financial Performance
10.6.4.3. Product Benchmarking
10.6.4.4. Recent Developments
10.6.5. BD
10.6.5.1. Participant’s Overview
10.6.5.2. Financial Performance
10.6.5.3. Product Benchmarking
10.6.5.4. Recent Developments
10.6.6. QIAGEN
10.6.6.1. Participant’s Overview
10.6.6.2. Financial Performance
10.6.6.3. Product Benchmarking
10.6.6.4. Recent Developments
10.6.7. Quidel Corporation
10.6.7.1. Participant’s Overview
10.6.7.2. Financial Performance
10.6.7.3. Product Benchmarking
10.6.7.4. Recent Developments
10.6.8. F. Hoffmann-La Roche Ltd.
10.6.8.1. Participant’s Overview
10.6.8.2. Financial Performance
10.6.8.3. Product Benchmarking
10.6.8.4. Recent Developments
10.6.9. Danaher
10.6.9.1. Participant’s Overview
10.6.9.2. Financial Performance
10.6.9.3. Product Benchmarking
10.6.9.4. Recent Developments
10.6.10. Randax Laboratories
10.6.10.1. Participant’s Overview
10.6.10.2. Financial Performance
10.6.10.3. Product Benchmarking
10.6.10.4. Recent Developments
10.6.11. Agilent Technologies, Inc.
10.6.11.1. Participant’s Overview
10.6.11.2. Financial Performance
10.6.11.3. Product Benchmarking
10.6.11.4. Recent Developments
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Regulatory Framework
Table 4 MEA Middle East in Vitro Diagnostics Market, by Country, 2021-2033 (USD Million)
Table 5 MEA Middle East in Vitro Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 6 MEA Middle East in Vitro Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 7 MEA Middle East in Vitro Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 8 MEA Middle East in Vitro Diagnostics Market, by End-use, 2021-2033 (USD Million)
Table 9 MEA Middle East in Vitro Diagnostics Market, by Test Location, 2021-2033 (USD Million)
Table 10 Qatar Middle East in Vitro Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 11 Qatar Middle East in Vitro Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 12 Qatar Middle East in Vitro Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 13 Qatar Middle East in Vitro Diagnostics Market, by End-use, 2021-2033 (USD Million)
Table 14 UAE Middle East in Vitro Diagnostics Market, by Test Location, 2021-2033 (USD Million)
Table 15 UAE Middle East in Vitro Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 16 UAE Middle East in Vitro Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 17 UAE Middle East in Vitro Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 18 UAE Middle East in Vitro Diagnostics Market, by End-use, 2021-2033 (USD Million)
Table 19 UAE Middle East in Vitro Diagnostics Market, by Test Location, 2021-2033 (USD Million)
Table 20 Saudi Arabia Middle East in Vitro Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 21 Saudi Arabia Middle East in Vitro Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 22 Saudi Arabia Middle East in Vitro Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 23 Saudi Arabia Middle East in Vitro Diagnostics Market, by End-use, 2021-2033 (USD Million)
Table 24 Saudi Arabia Middle East in Vitro Diagnostics Market, by Test Location, 2021-2033 (USD Million)
Table 25 Oman Middle East in Vitro Diagnostics Market, by Test Location, 2021-2033 (USD Million)
Table 26 Oman Middle East in Vitro Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 27 Oman Middle East in Vitro Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 28 Oman Middle East in Vitro Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 29 Oman Middle East in Vitro Diagnostics Market, by End-use, 2021-2033 (USD Million)
Table 30 Oman Middle East in Vitro Diagnostics Market, by Test Location, 2021-2033 (USD Million)
Table 31 Kuwait Middle East in Vitro Diagnostics Market, by Test Location, 2021-2033 (USD Million)
Table 32 Kuwait Middle East in Vitro Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 33 Kuwait Middle East in Vitro Diagnostics Market, by Technology, 2021-2033 (USD Million)
Table 34 Kuwait Middle East in Vitro Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 35 Kuwait Middle East in Vitro Diagnostics Market, by End-use, 2021-2033 (USD Million)
Table 36 Kuwait Middle East in Vitro Diagnostics Market, by Test Location, 2021-2033 (USD Million)
List of Figures
Figure 1 Middle East in Vitro Diagnostics market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 QFD modeling for market share assessment
Figure 8 Market formulation & validation
Figure 9 in vitro diagnostic market snapshot
Figure 10 Parent market outlook, 2024
Figure 11 in vitro diagnostic market driver impact
Figure 12 MEAelderly population
Figure 13 New cancer cases by year
Figure 14 in vitro diagnostic market restraint impact
Figure 15 Market entry strategy
Figure 16 SWOT analysis, by factor (political & legal, economic, and technological)
Figure 17 Porter’s five forces analysis
Figure 18 IVD market: Product outlook and key takeaways
Figure 19 IVD market: Products movement analysis
Figure 20 Instruments market estimates and forecast, 2021-2033 (USD Million)
Figure 21 Reagents market estimates and forecast, 2021-2033 (USD Million)
Figure 22 Services market estimates and forecast, 2021-2033 (USD Million)
Figure 23 IVD market: Technology outlook and key takeaways
Figure 24 IVD Market: Technology movement analysis
Figure 25 Immunoassay market estimates and forecast, 2021-2033 (USD Million)
Figure 26 Instruments market for immunoassay estimates and forecast, 2021-2033 (USD Million)
Figure 27 Reagents market for immunoassay estimates and forecast, 2021-2033 (USD Million)
Figure 28 Services market for immunoassay estimates and forecast, 2021-2033 (USD Million)
Figure 29 Hematology market estimates and forecast, 2021-2033 (USD Million)
Figure 30 Instruments market for hematology estimates and forecast, 2021-2033 (USD Million)
Figure 31 Reagents market for hematology estimates and forecast, 2021-2033 (USD Million)
Figure 32 Services market for hematology estimates and forecast, 2021-2033 (USD Million)
Figure 33 Clinical chemistry market estimates and forecast, 2021-2033 (USD Million)
Figure 34 Instruments market for clinical chemistry estimates and forecast, 2021-2033 (USD Million)
Figure 35 Reagents market for clinical chemistry estimates and forecast, 2021-2033 (USD Million)
Figure 36 Services market for clinical chemistry estimates and forecast, 2021-2033 (USD Million)
Figure 37 Molecular diagnostics market estimates and forecast, 2021-2033 (USD Million)
Figure 38 Instruments market for molecular diagnostics estimates and forecast, 2021-2033 (USD Million)
Figure 39 Reagents market for molecular diagnostics estimates and forecast, 2021-2033 (USD Million)
Figure 40 Services market for molecular diagnostics estimates and forecast, 2021-2033 (USD Million)
Figure 41 Coagulation market estimates and forecast, 2021-2033 (USD Million)
Figure 42 Instruments market for coagulation estimates and forecast, 2021-2033 (USD Million)
Figure 43 Reagents market for coagulation estimates and forecast, 2021-2033 (USD Million)
Figure 44 Services market for coagulation estimates and forecast, 2021-2033 (USD Million)
Figure 45 Microbiology market estimates and forecast, 2021-2033 (USD Million)
Figure 46 Instruments market for microbiology estimates and forecast, 2021-2033 (USD Million)
Figure 47 Reagents market for microbiology estimates and forecast, 2021-2033 (USD Million)
Figure 48 Services market for microbiology estimates and forecast, 2021-2033 (USD Million)
Figure 49 Others market estimates and forecast, 2021-2033 (USD Million)million,
Figure 50 Instruments others market estimates and forecast, 2021-2033 (USD Million)
Figure 51 Reagents others market estimates and forecast, 2021-2033 (USD Million)
Figure 52 Services market for other technology estimates and forecast, 2021-2033 (USD Million)
Figure 53 IVD market: Application outlook and key takeaways
Figure 54 IVD market: Application movement analysis
Figure 55 Infectious diseases market estimates and forecast, 2021-2033 (USD Million)
Figure 56 Diabetes market estimates and forecast, 2021-2033 (USD Million)
Figure 57 Oncology market estimates and forecast, 2021-2033 (USD Million)
Figure 58 Cardiology market estimates and forecast, 2021-2033 (USD Million)
Figure 59 Nephrology market estimates and forecast, 2021-2033 (USD Million)
Figure 60 Autoimmune diseases market estimates and forecast, 2021-2033 (USD Million)
Figure 61 Drug testing market estimates and forecast, 2021-2033 (USD Million)
Figure 62 Others market estimates and forecast, 2021-2033 (USD Million)
Figure 63 IVD market: End-use outlook and key takeaways
Figure 64 IVD treatment market: End-use movement analysis
Figure 65 Hospitals market estimates and forecast, 2021-2033 (USD Million)
Figure 66 Laboratory market estimates and forecast, 2021-2033 (USD Million)
Figure 67 Home care market estimates and forecast, 2021-2033 (USD Million)
Figure 68 Other market estimates and forecast, 2021-2033 (USD Million)
Figure 69 IVD market: test location outlook and key takeaways
Figure 70 IVD treatment market: Test location movement analysis
Figure 71 Point-of-care market estimates and forecast, 2021-2033 (USD Million)
Figure 72 Homecare market estimates and forecast, 2021-2033 (USD Million)
Figure 73 Others market estimates and forecast, 2021-2033 (USD Million)
Figure 74 IVD Market: Regional outlook and key takeaways
Figure 75 IVD market: Regional movement analysis
Figure 76 MEA key country dynamics
Figure 77 MEA market estimates and forecast, 2021-2033 (USD Million)
Figure 78 Qatar key country dynamics
Figure 79 Qatar market estimates and forecast, 2021-2033 (USD Million)
Figure 80 UAE key country dynamics
Figure 81 UAE market estimates and forecast, 2021-2033 (USD Million)
Figure 82 Saudi Arabia key country dynamics
Figure 83 Saudi Arabia market estimates and forecast, 2021-2033 (USD Million)
Figure 84 Oman key country dynamics
Figure 85 Oman market estimates and forecast, 2021-2033 (USD Million)
Figure 86 Kuwait key country dynamics
Figure 87 Kuwait market estimates and forecast, 2021-2033 (USD Million)
Figure 88 Ansoff matrix
Figure 89 Competition categorization
Figure 90 Company market share analysis, 2024

Companies Mentioned

The major companies profiled in this Middle East in Vitro Diagnostics market report include:
  • Abbott
  • Bio-Rad Laboratories, Inc
  • Siemens Healthineers AG
  • BIOMÉRIEUX
  • BD
  • QIAGEN
  • Quidel Corporation
  • F. Hoffmann-La Roche Ltd.
  • Danaher
  • Quest Diagnostics Incorporated
  • Agilent Technologies, Inc.

Table Information

Report AttributeDetails
No. of Pages320
PublishedAugust 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 2.09 Billion
Forecasted Market Value ( USD ) by 2033 $ 3.79 Billion
Compound Annual Growth Rate7.2%
Regions CoveredMiddle East
No. of Companies Mentioned12

Related Topics

Related Reports

In Vitro Diagnostics Market, Industry Trends and Global Forecasts to 2035: Distribution by Test Type, Type of Offering, Type of Technology, Therapeutic Area, End Users and Geographical Regions - Product Image

In Vitro Diagnostics Market, Industry Trends and Global Forecasts to 2035: Distribution by Test Type, Type of Offering, Type of Technology, Therapeutic Area, End Users and Geographical Regions

  • Report
  • 188 Pages
  • Global
From
U.S. In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents, Services), By Technology (Immunoassay, Molecular Diagnostics), By Application (Infectious Disease), By Test Location, By End Use, And Segment Forecasts, 2025 - 2030 - Product Image

U.S. In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents, Services), By Technology (Immunoassay, Molecular Diagnostics), By Application (Infectious Disease), By Test Location, By End Use, And Segment Forecasts, 2025 - 2030

  • Report
  • 358 Pages
  • United States
From
In-Vitro Diagnostic Market - North America and Country Analysis: Focus on Product, Test Type, Application, End User, and Country Analysis - Analysis and Forecast, 2025-2035 - Product Image

In-Vitro Diagnostic Market - North America and Country Analysis: Focus on Product, Test Type, Application, End User, and Country Analysis - Analysis and Forecast, 2025-2035

  • Report
  • North America
From
Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course (April 16-17, 2026) - Product Image

Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course (April 16-17, 2026)

  • Training
  • 2 Days
  • Global
GCC In Vitro Diagnostics Market Report by Test Type, Product, Usability, Application, End User, and Country 2025-2033 - Product Image

GCC In Vitro Diagnostics Market Report by Test Type, Product, Usability, Application, End User, and Country 2025-2033

  • Report
  • 135 Pages
  • Middle East
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.